Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113631514 | 11363151 | 4 | F | 20150312 | 20160729 | 20150811 | 20160804 | EXP | PHHY2015DE092570 | NOVARTIS | 40.19 | YR | F | Y | 75.00000 | KG | 20160804 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113631514 | 11363151 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 56.1399994 | MG | Y | 22527 | .5 | MG | CAPSULE | QD | |||
| 113631514 | 11363151 | 2 | C | QUETIAPIN | QUETIAPINE | 1 | Unknown | 25 MG, QD (0-0-1) | U | 0 | 25 | MG | QD | ||||||
| 113631514 | 11363151 | 3 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | 30 MG, UNK | U | 0 | 30 | MG | |||||||
| 113631514 | 11363151 | 4 | C | L-THYROXIN | LEVOTHYROXINE SODIUM | 1 | Unknown | 50 UG, QD (1-0-0), SINCE MANY YEARS | U | 0 | 50 | UG | QD | ||||||
| 113631514 | 11363151 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, QD (1-0-0) | U | 0 | QD | ||||||||
| 113631514 | 11363151 | 6 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 OT, BID | U | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113631514 | 11363151 | 1 | Relapsing-remitting multiple sclerosis |
| 113631514 | 11363151 | 2 | Sleep disorder |
| 113631514 | 11363151 | 3 | Depression |
| 113631514 | 11363151 | 4 | Thyroid disorder |
| 113631514 | 11363151 | 5 | Product used for unknown indication |
| 113631514 | 11363151 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113631514 | 11363151 | HO |
| 113631514 | 11363151 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113631514 | 11363151 | Arthralgia | |
| 113631514 | 11363151 | Decreased appetite | |
| 113631514 | 11363151 | Epigastric discomfort | |
| 113631514 | 11363151 | Gastritis | |
| 113631514 | 11363151 | Gastrooesophageal reflux disease | |
| 113631514 | 11363151 | Liver function test increased | |
| 113631514 | 11363151 | Low density lipoprotein increased | |
| 113631514 | 11363151 | Nausea | |
| 113631514 | 11363151 | Vitamin D deficiency | |
| 113631514 | 11363151 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113631514 | 11363151 | 1 | 20150120 | 20150625 | 0 | |
| 113631514 | 11363151 | 2 | 201305 | 0 | ||
| 113631514 | 11363151 | 3 | 20150311 | 0 |